Joining AI Drug Discovery Race, Erasca Adds $22M For Cancer Work

Joining AI Drug Discovery Race, Erasca Adds $22M For Cancer Work

Source: 
Xconomy
snippet: 

Erasca, a biotech startup run by the former CEO of Ignyta, debuted in December with $42 million and an audacious plan to “erase cancer,” but provided little explanation as to how.